Millipore Sigma Vibrant Logo
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più

345832 Galectin-3C, Human, Recombinant, E. coli

Galectin-3C, Human, Recombinant, E. coli: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.
345832
Purchase on Sigma-Aldrich

Panoramica

Replacement Information

Products

Numero di catalogoConfezionamento Qtà/conf
345832-100UG Fiala di plastica 100 μg
Description
OverviewRecombinant, human galectin-3 expressed in E. coli and subsequently cleaved with Clostridium histolyticum collagenase type VII to yield galectin-3C. The resulting galectin-3C is purified by affinity chromatography. Galectin-3C is a truncated form of galectin-3 that contains the carbohydrate binding domain but lacks the 107 amino acids at the N-terminus of galectin-3. It is suggested to play a key role in autoimmune diseases, allergic reactions, inflammation, tumor cell metastasis, atherosclerosis, and diabetes.
Catalogue Number345832
Brand Family Calbiochem®
References
ReferencesHoyer K.K., et al. 2004. Am. J. Pathol. 164, 893.
John C.M., et al. 2003. Clin. Cancer Res. 9, 2374.
Iurisci, I., et al. 2000. Clin Cancer Res 6, 1389.
Van Den Brule, F. A., et al. 2000. Int. J. Cancer 89, 361.
Inohara, H. 1999. Cancer 85, 2475.
Nakamura, M., et al. 1999. Int. J. Oncol. 15, 143.
Idikio, H., et al. 1998. Int. J. Oncol. 12, 1287.
Ochieng, J., et al. 1998. Biochim. Biophys. Acta. 1379 97.
Castronovo, V., et al. 1996. J. Pathol. 179, 43.
Liu, F.T., et al. 1996. Biochemistry 35 6073.
Schoeppner, H. L., et al. 1995. Cancer 75, 2818.
Massa, S.M., et al. 1993. Biochemistry 32, 260.
Oda, Y., et al. 1991. Gene 99, 279.
Product Information
FormLyophilized
FormulationLyophilized from deionized water, 2µg lactose/µg lectin.
Quality LevelMQ100
Applications
Biological Information
Purity≥95% by SDS-PAGE
Physicochemical Information
ContaminantsEndotoxin: ≤ 1 EU/µg protein
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Blue Ice Only
Toxicity Standard Handling
Storage -20°C
Avoid freeze/thaw Avoid freeze/thaw
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions (in the presence of a molar excess of lactose) are stable for up to 4 months at -20°C. For use in carbohydrate binding assays the solution should be dialyzed to remove the lactose stabilizer.
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numero di catalogo GTIN
345832-100UG 04055977214352

Documentation

Galectin-3C, Human, Recombinant, E. coli MSDS

Titolo

Scheda di sicurezza (MSDS) 

Galectin-3C, Human, Recombinant, E. coli Certificati d'Analisi

TitoloNumero di lotto
345832

Riferimenti bibliografici

Panoramica delle referenze
Hoyer K.K., et al. 2004. Am. J. Pathol. 164, 893.
John C.M., et al. 2003. Clin. Cancer Res. 9, 2374.
Iurisci, I., et al. 2000. Clin Cancer Res 6, 1389.
Van Den Brule, F. A., et al. 2000. Int. J. Cancer 89, 361.
Inohara, H. 1999. Cancer 85, 2475.
Nakamura, M., et al. 1999. Int. J. Oncol. 15, 143.
Idikio, H., et al. 1998. Int. J. Oncol. 12, 1287.
Ochieng, J., et al. 1998. Biochim. Biophys. Acta. 1379 97.
Castronovo, V., et al. 1996. J. Pathol. 179, 43.
Liu, F.T., et al. 1996. Biochemistry 35 6073.
Schoeppner, H. L., et al. 1995. Cancer 75, 2818.
Massa, S.M., et al. 1993. Biochemistry 32, 260.
Oda, Y., et al. 1991. Gene 99, 279.
Scheda tecnica

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision30-June-2008 RFH
DescriptionRecombinant, human galectin-3 expressed in E. coli and subsequently cleaved with Clostridium histiolyticum collagenase type VII to yield galectin-3C. The resulting galectin-3C is purified by affinity chromatography. Galectin-3C is a truncated form of galectin-3 that contains the carbohydrate binding domain but lacks the 107 amino acids at the N-terminus of galectin-3. It is suggested to play a key role in autoimmune diseases, allergic reactions, inflammation, tumor cell metastasis, atherosclerosis, and diabetes.
FormLyophilized
FormulationLyophilized from deionized water, 2µg lactose/µg lectin.
Purity≥95% by SDS-PAGE
ContaminantsEndotoxin: ≤ 1 EU/µg protein
SolubilitySterile PBS (1 mg/ml)
Storage Avoid freeze/thaw
-20°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions (in the presence of a molar excess of lactose) are stable for up to 4 months at -20°C. For use in carbohydrate binding assays the solution should be dialyzed to remove the lactose stabilizer.
Toxicity Standard Handling
ReferencesHoyer K.K., et al. 2004. Am. J. Pathol. 164, 893.
John C.M., et al. 2003. Clin. Cancer Res. 9, 2374.
Iurisci, I., et al. 2000. Clin Cancer Res 6, 1389.
Van Den Brule, F. A., et al. 2000. Int. J. Cancer 89, 361.
Inohara, H. 1999. Cancer 85, 2475.
Nakamura, M., et al. 1999. Int. J. Oncol. 15, 143.
Idikio, H., et al. 1998. Int. J. Oncol. 12, 1287.
Ochieng, J., et al. 1998. Biochim. Biophys. Acta. 1379 97.
Castronovo, V., et al. 1996. J. Pathol. 179, 43.
Liu, F.T., et al. 1996. Biochemistry 35 6073.
Schoeppner, H. L., et al. 1995. Cancer 75, 2818.
Massa, S.M., et al. 1993. Biochemistry 32, 260.
Oda, Y., et al. 1991. Gene 99, 279.